<SEC-DOCUMENT>0001104659-24-077093.txt : 20240702
<SEC-HEADER>0001104659-24-077093.hdr.sgml : 20240702
<ACCEPTANCE-DATETIME>20240702081402
ACCESSION NUMBER:		0001104659-24-077093
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20240702
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240702
DATE AS OF CHANGE:		20240702

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Annovis Bio, Inc.
		CENTRAL INDEX KEY:			0001477845
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				262540421
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39202
		FILM NUMBER:		241092954

	BUSINESS ADDRESS:	
		STREET 1:		101 LINDENWOOD DRIVE, SUITE 225
		CITY:			MALVERN
		STATE:			PA
		ZIP:			19355
		BUSINESS PHONE:		484-875-3192

	MAIL ADDRESS:	
		STREET 1:		101 LINDENWOOD DRIVE, SUITE 225
		CITY:			MALVERN
		STATE:			PA
		ZIP:			19355

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	QR Pharma, Inc.
		DATE OF NAME CHANGE:	20091202
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2418712d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:ANVS="http://annovisbio.com/20240702">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_032_ANVS_annovisbio.com_20240702 -->
<!-- Field: Set; Name: xdx; ID: xdx_044_20240702_20240702 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_054_edei%2D%2DEntityCentralIndexKey_0001477845 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2024-07-02" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-07-02" id="Fact000004" name="dei:EntityCentralIndexKey">0001477845</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="anvs-20240702.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2024-07-02">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001477845</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-02</xbrli:startDate>
        <xbrli:endDate>2024-07-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&#160;</p>



<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WASHINGTON, DC 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 8pt"></span>&#160;</p>

<p style="border-top: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 18pt"><b>FORM <span id="xdx_902_edei--DocumentType_c20240702__20240702_zUAomE9zbyNk"><ix:nonNumeric contextRef="AsOf2024-07-02" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p>

<p style="border-top: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt">&#160;</span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section&#160;13 or 15(d) of the</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Securities Exchange Act of 1934</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Date of report (Date of earliest event reported):
<span id="xdx_90B_edei--DocumentPeriodEndDate_c20240702__20240702_zzaj0VYXItKd"><ix:nonNumeric contextRef="AsOf2024-07-02" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">July 2, 2024</ix:nonNumeric></span></b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="border-top: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;&#160;</p>

<p style="font: 21pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90C_edei--EntityRegistrantName_c20240702__20240702_zWx18va6xmMa"><ix:nonNumeric contextRef="AsOf2024-07-02" id="Fact000011" name="dei:EntityRegistrantName">ANNOVIS BIO, INC.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Exact Name of Registrant as Specified in Charter)</b><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="border-top: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>



<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top; text-align: center; width: 33%"><b><span id="xdx_90C_edei--EntityIncorporationStateCountryCode_c20240702__20240702_zzHNw3OcTf3d"><ix:nonNumeric contextRef="AsOf2024-07-02" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></td>
    <td style="vertical-align: top; text-align: center; width: 34%"><b><span id="xdx_90E_edei--EntityFileNumber_c20240702__20240702_zEfrscg2GUh7"><ix:nonNumeric contextRef="AsOf2024-07-02" id="Fact000013" name="dei:EntityFileNumber">001-39202</ix:nonNumeric></span></b></td>
    <td style="vertical-align: top; text-align: center; width: 33%"><b><span id="xdx_90F_edei--EntityTaxIdentificationNumber_c20240702__20240702_zGyBQyi1nYdb"><ix:nonNumeric contextRef="AsOf2024-07-02" id="Fact000014" name="dei:EntityTaxIdentificationNumber">26-2540421</ix:nonNumeric></span></b></td></tr>
  <tr>
    <td style="text-align: center; vertical-align: top">
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(State or Other Jurisdiction</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>of Incorporation)</b></p></td>
    <td style="text-align: center; vertical-align: top">
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(Commission</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>File Number)</b></p></td>
    <td style="text-align: center; vertical-align: top">
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(I.R.S. Employer</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Identification No.)</b></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_902_edei--EntityAddressAddressLine1_c20240702__20240702_zq2I7glG0F15"><b><ix:nonNumeric contextRef="AsOf2024-07-02" id="Fact000015" name="dei:EntityAddressAddressLine1">101
Lindenwood Drive</ix:nonNumeric></b></span><b>, <span id="xdx_90A_edei--EntityAddressAddressLine2_c20240702__20240702_zQBz3m0smDue"><ix:nonNumeric contextRef="AsOf2024-07-02" id="Fact000016" name="dei:EntityAddressAddressLine2">Suite 225</ix:nonNumeric></span></b><b><br/>
<span id="xdx_903_edei--EntityAddressCityOrTown_c20240702__20240702_zjJ0nsw64wz"><ix:nonNumeric contextRef="AsOf2024-07-02" id="Fact000017" name="dei:EntityAddressCityOrTown">Malvern</ix:nonNumeric></span></b><b>, <span id="xdx_90C_edei--EntityAddressStateOrProvince_c20240702__20240702_zCV2taiu5rT9"><ix:nonNumeric contextRef="AsOf2024-07-02" id="Fact000018" name="dei:EntityAddressStateOrProvince">PA</ix:nonNumeric>
</span></b><b><span id="xdx_90F_edei--EntityAddressPostalZipCode_c20240702__20240702_zw83S0j6Xwoe"><ix:nonNumeric contextRef="AsOf2024-07-02" id="Fact000019" name="dei:EntityAddressPostalZipCode">19355</ix:nonNumeric> </span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Address of Principal Executive Offices, and
Zip Code)</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(<span id="xdx_902_edei--CityAreaCode_c20240702__20240702_z62h4DPyMF47"><ix:nonNumeric contextRef="AsOf2024-07-02" id="Fact000020" name="dei:CityAreaCode">484</ix:nonNumeric></span>) <span id="xdx_907_edei--LocalPhoneNumber_c20240702__20240702_zcadLsDMBPBe"><ix:nonNumeric contextRef="AsOf2024-07-02" id="Fact000021" name="dei:LocalPhoneNumber">875-3192</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Registrant&#8217;s Telephone Number, Including
Area Code</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration: underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Not
Applicable&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Former Name or Former Address, if Changed Since
Last Report)</b>&#160;</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Securities registered pursuant to Section 12(b)
of the Act:</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border: Black 1pt solid; width: 37%; padding-right: 5.4pt; padding-bottom: 2.2pt; padding-left: 5.4pt; text-align: center"><b>Title of each class</b></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 24%; padding-right: 5.4pt; padding-bottom: 2.2pt; padding-left: 5.4pt; text-align: center"><b>Trading Symbol(s)</b></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 39%; padding-right: 5.4pt; padding-bottom: 2.2pt; padding-left: 5.4pt; text-align: center"><b>Name
    of each exchange on which<br/>
 registered</b></td></tr>
  <tr style="vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><b><span id="xdx_901_edei--Security12bTitle_c20240702__20240702_zH3Iio2UfPde"><ix:nonNumeric contextRef="AsOf2024-07-02" id="Fact000022" name="dei:Security12bTitle">Common Stock, par value $0.0001 per share</ix:nonNumeric></span></b></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 2.2pt; padding-left: 5.4pt; text-align: center"><b><span id="xdx_902_edei--TradingSymbol_c20240702__20240702_z9I7jKDzufsj"><ix:nonNumeric contextRef="AsOf2024-07-02" id="Fact000023" name="dei:TradingSymbol">ANVS</ix:nonNumeric></span></b></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 2.2pt; padding-left: 5.4pt; text-align: center"><b><span id="xdx_90C_edei--SecurityExchangeName_c20240702__20240702_zDqbUuwpcfE6"><ix:nonNumeric contextRef="AsOf2024-07-02" format="ixt-sec:exchnameen" id="Fact000024" name="dei:SecurityExchangeName">New York Stock Exchange</ix:nonNumeric></span></b></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<!-- Field: Rule-Page --><div style="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><div style="border-top: Black 0.75pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 8pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<i>see</i> General Instruction
A.2. below):</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 4%">&#160;</td>
    <td style="vertical-align: top; width: 4%"><span style="font-family: Wingdings"><span id="xdx_905_edei--WrittenCommunications_c20240702__20240702_zou7EwuvRGOk"><ix:nonNumeric contextRef="AsOf2024-07-02" format="ixt:booleanfalse" id="Fact000025" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify; vertical-align: top; width: 92%">Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</td></tr>
  </table>
<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 4%">&#160;</td>
    <td style="vertical-align: top; width: 4%"><span style="font-family: Wingdings"><span style="font-family: Wingdings"><span style="font-family: Wingdings"><span id="xdx_905_edei--SolicitingMaterial_c20240702__20240702_z3CKsOzVuYhf"><ix:nonNumeric contextRef="AsOf2024-07-02" format="ixt:booleanfalse" id="Fact000026" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></span></span></td>
    <td style="text-align: justify; vertical-align: top; width: 92%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</td></tr>
  </table>
<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 4%">&#160;</td>
    <td style="vertical-align: top; width: 4%"><span style="font-family: Wingdings"><span style="font-family: Wingdings"><span id="xdx_909_edei--PreCommencementTenderOffer_c20240702__20240702_zyfpA8x1N4gb"><ix:nonNumeric contextRef="AsOf2024-07-02" format="ixt:booleanfalse" id="Fact000027" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="text-align: justify; vertical-align: top; width: 92%">Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</td></tr>
  </table>
<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top; text-align: justify">
<td style="width: 4%"/><td style="width: 4%; text-align: left"><span style="font-family: Wingdings"><span id="xdx_906_edei--PreCommencementIssuerTenderOffer_c20240702__20240702_zOVt4fFARvx3"><ix:nonNumeric contextRef="AsOf2024-07-02" format="ixt:booleanfalse" id="Fact000028" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></td><td style="text-align: justify; width: 92%">Pre-commencement communication pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c))</td>
</tr></table>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &#167;240.12b-2).</p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Emerging growth company <span style="font-family: Wingdings"><span id="xdx_907_edei--EntityEmergingGrowthCompany_c20240702__20240702_zD4aen7xSt94"><ix:nonNumeric contextRef="AsOf2024-07-02" format="ixt:booleantrue" id="Fact000029" name="dei:EntityEmergingGrowthCompany">x</ix:nonNumeric></span>
</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 8pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family: Wingdings"><span id="xdx_905_edei--EntityExTransitionPeriod_c20240702__20240702_z9wpNEqqkFk"><ix:nonNumeric contextRef="AsOf2024-07-02" format="ixt:booleanfalse" id="Fact000030" name="dei:EntityExTransitionPeriod">&#168;</ix:nonNumeric></span>
</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 8pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 7.01 Regulation FD Disclosure</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">On July&#160;2, 2024,
Annovis Bio,&#160;Inc. (&#8220;The Company&#8221;) issued a press release announcing new data from its Phase III Parkinson&#8217;s study.
A copy of the press release is attached as Exhibit&#160;99.1 to this Current Report on Form&#160;8-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company plans to hold a webcast at 4:30 PM ET, after market close o</span>n July&#160;2, 2024, to discuss the study findings in detail.
A registration link can be found in the  copy of this press release posted on the Investors section of our website.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
9.01</b></span>&#160;<b>Financial Statements and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The following exhibits
are being furnished herewith:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>(d)&#160;Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 164px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit&#160;No.&#160;</b></span></td>
    <td style="width: 18px">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr>
    <td><a href="tm2418712d1_ex99-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></a></td>
    <td>&#160;</td>
    <td><a href="tm2418712d1_ex99-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press Release Dated July&#160;2, 2024</span></a></td></tr>
  <tr style="background-color: transparent">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page&#160;Interactive Data File</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration: underline">SIGNATURES</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ANNOVIS
    BIO,&#160;INC.</b></span></td></tr>
  <tr>
    <td style="width: 50%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 3%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 47%"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: July&#160;2, 2024</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom"><span style="font-size: 10pt">/s/ Maria Maccecchini</span></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: </span><span style="font-size: 10pt">Maria
    Maccecchini</span></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: President and
    Chief Executive Officer</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjVEKwjAQRE/QOyz5Fk1CReinRUWsIkXE32BXCbbZsolVj+QtjS3isrAsM29GiJFY0dLWyHCalwUcsGlrExBKvCCjO2N05OtNBvGWeLU+sHGhf39gTpHByEzHWp+j0Fs767HKQM4mUk10CkpmqYL9ViRfPSd3sRW6YE0NxlWwZ2rZYjD8GhIO5kmOmldfdUT2llwGaiwH+Q1aKg076syD+OahKHKRjPpJxIrp3kbX4hnQfUlY1NjEOj/Q/00+BBFKiA== -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tm2418712d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exhibit 99.1</B><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>Annovis Bio Announces New Data from
Phase III Parkinson&rsquo;s Study Highlighting Improvements in Unified Parkinson's Disease Rating Scale (MDS-UPDRS) and Cognition after
Treatment with Buntanetap</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><I>Buntanetap showed
dose-dependent and statistically significant improvements in cognition in the overall enrolled PD population. Parkinson&rsquo;s patients
with substantial cognitive decline exhibited a very pronounced improvement.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><I>Buntanetap showed
statistical improvement in the MDS-UPDRS Part&nbsp;II, Part&nbsp;III, Part&nbsp;II+III and Total scores in Parkinson&rsquo;s patients
with a &gt;3-year diagnosis.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><I>Buntanetap showed
the same statistical improvement in MDS-UPDRS Part&nbsp;II, Part&nbsp;III, Part&nbsp;II+III and Total scores in Parkinson&rsquo;s patients
with Postural Instability and Gait Difficulties (PIGD).</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><I>Buntanetap&rsquo;s
activity resulted in statistically significant improvements in all primary and secondary endpoints in the specified populations as
well as in cognition.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">MALVERN, Pa., July&nbsp;2, 2024 (GLOBE
NEWSWIRE) -- via IBN &ndash; <U>Annovis Bio Inc.</U> (NYSE: ANVS) (&ldquo;Annovis&rdquo; or the &ldquo;Company&rdquo;), a late-stage
clinical drug platform company pioneering transformative therapies for neurodegenerative disorders such as Alzheimer&rsquo;s Disease
(AD) and Parkinson&rsquo;s Disease (PD), today announced new data from its Phase III PD study demonstrating that buntanetap is safe and
effective in improving motor and non-motor activities and improving cognitive functions in patients with early Parkinson&rsquo;s disease.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">These findings will be discussed in
more detail on today's webcast at 4:30 PM ET. <U>Register here.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&quot;We are very pleased to see improvements
in many of our patients over such a short course of treatment. These compelling data reinforce our commitment to advancing buntanetap
into a longer study, which will allow us not only to verify observed symptomatic improvements but also to explore buntanetap&rsquo;s
disease-modifying properties,&quot; said Maria Maccecchini, Ph.D., Founder, President and CEO of Annovis Bio.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>Key Findings from the Study:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><FONT STYLE="font-size: 10pt"><B>Buntanetap stops cognitive
decline in all enrolled patients (MMSE 20-30) and improves cognition in patients with mild dementia (MMSE 20-26).</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">o</FONT></TD><TD><FONT STYLE="font-size: 10pt"><B>Findings:
                                            </B>In the entire enrolled population, placebo group demonstrated cognition deterioration
                                            throughout the study, whereas all treatment groups (10mg and 20mg buntanetap) maintained
                                            baseline levels, indicating a statistically significant effect of the drug in stopping cognitive
                                            decline. In patients with mild dementia, as measured by MMSE 20-26, cognition deteriorated
                                            at a faster pace in the placebo group compared to those treated with 10mg buntanetap. Moreover,
                                            treatment with 20mg buntanetap showed significant improvement in cognition compared to placebo
                                            (Figure 1).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">o</FONT></TD><TD><FONT STYLE="font-size: 10pt"><B>Background:
                                            </B>Inclusion criteria for enrollment included MMSE scores between 20-30, and MMSE scores
                                            were measured again at the end of the study as an exploratory endpoint. This allowed us to
                                            determine changes in cognition in the entire enrolled population as well as in patients with
                                            cognitive decline. Most PD patients had normal cognitive functioning, and just 12% showed
                                            cognitive decline as measured by MMSE 20-26. These patients declined by 1.5 MMSE points in
                                            the placebo group but did not decline at all and even improved when treated with buntanetap.
                                            This data aligns with our AD cognition data, where patients with MMSE&gt;20 responded well
                                            to buntanetap, showing statistically significant cognitive improvement in early AD patients.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><IMG SRC="tm2418712d1_ex99-1img001.jpg" ALT="" STYLE="height: 241px; width: 523px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">Figure 1. Changes
in MMSE after treatment with 10mg or 20mg buntanetap compared to baseline and placebo.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><FONT STYLE="font-size: 10pt"><B>Buntanetap improves motor
and non-motor PD-related functions in patients with a diagnosis of over 3 years.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">o</FONT></TD><TD><FONT STYLE="font-size: 10pt"><B>Findings:
                                            </B>Patients with a diagnosis of less than 3 years showed minimal or no deficits in MDS-UPDRS
                                            Part&nbsp;II, making it challenging to measure improvement and assess treatment effectiveness.
                                            However, in patients diagnosed with PD for longer than 3 years (MH&gt;3), with measurable
                                            declines in MDS-UPDRS Part&nbsp;II, 20mg buntanetap significantly improved MDS-UPDRS Part&nbsp;II,
                                            Part&nbsp;III, Part&nbsp;II+III, and Total scores compared to placebo and baseline (Figure
                                            2).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">o</FONT></TD><TD><FONT STYLE="font-size: 10pt"><B>Background:
                                            </B>Longitudinal studies from Parkinson&rsquo;s Progressive Markers Initiative (PPMI) cohorts
                                            have shown that Parkinson patients&rsquo; self-evaluation of their activities of daily living
                                            (MDS-UPDRS Part&nbsp;II) are relatively intact in the early disease stages. They have also
                                            shown that MDS-UPDRS Part&nbsp;II deteriorates at a much slower pace compared to the physician-scored
                                            motor evaluation (MDS-UPDRS Part&nbsp;III <I>(Holden et al. 2017)</I>.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><IMG SRC="tm2418712d1_ex99-1img002.jpg" ALT="" STYLE="height: 378px; width: 424px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">Figure 2. Changes
in MDS-UPDRS after treatment with 10mg or 20mg buntanetap in patients with a PD diagnosis over 3 years compared to baseline and placebo.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><FONT STYLE="font-size: 10pt"><B>Buntanetap improves motor
and non-motor PD-related functions in patients with Postural Instability and Gait Difficulty (PIGD).</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">o</FONT></TD><TD><FONT STYLE="font-size: 10pt"><B>Findings:
                                            </B>PIGD patients treated with buntanetap showed significant improvements in MDS-UPDRS Part&nbsp;II,
                                            Part&nbsp;III, Part&nbsp;II-III, and Total scores. The disease in this patient group progresses
                                            faster than in other PD patients. Our data showed that PIGD patients respond better to buntanetap
                                            and improve further than other Parkinson&rsquo;s patients (Figure 3).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">o</FONT></TD><TD><FONT STYLE="font-size: 10pt"><B>Background:
                                            </B>Parkinson&rsquo;s is a very heterogeneous disease. Patients diagnosed with PIGD are considered
                                            to have faster disease progression <I>(Jankovic et al. 1990&nbsp;&amp; Stebbins et al. 2013</I>)
                                            than patients with no postural and gait issues. This observation provided us with the rationale
                                            to evaluate whether PIGD patients, who are at risk of faster decline, would benefit from
                                            buntanetap.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><IMG SRC="tm2418712d1_ex99-1img003.jpg" ALT="" STYLE="height: 398px; width: 490px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">Figure 3. Changes
in MDS-UPDRS after treatment with 10mg or 20mg buntanetap in patients with PIGD.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>Safety Profile: </B>Buntanetap maintained
a consistent safety profile across all participants, with no significant differences between early and advanced PD patients confirming
our previous AD data.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>FDA and Endpoint Clarification:</B>
Recent questions regarding the primary and secondary endpoints in MDS-UPDRS scores warrants additional explanation. Initially, Annovis
chose MDS-UPDRS Part&nbsp;II+III as the primary endpoint. However, based on FDA feedback, MDS-UPDRS Part&nbsp;II alone was deemed more
appropriate for reflecting clinically relevant changes (<I>Goetz et al., 2023</I>). Consequently, we adjusted our primary endpoint to
MDS-UPDRS Part&nbsp;II, with MDS-UPDRS Part&nbsp;III as a key secondary endpoint. Our results met both primary and secondary endpoints
in the specified subgroups.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>Upcoming Webcast</B><BR>
Annovis Bio will host an investor webcast today at 4:30 PM ET to discuss these findings in detail. Investors and interested parties are
encouraged to register for the webcast in advance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">To register, please visit <U>Webcast
Registration</U> and complete the registration form.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>About Buntanetap</B><BR>
Buntanetap (formerly known as Posiphen or ANVS401) targets neurodegeneration by inhibiting the formation of multiple neurotoxic proteins,
including amyloid beta, tau, alpha-synuclein, and TDP43. By improving synaptic transmission, axonal transport, and reducing neuroinflammation,
Buntanetap aims to reverse neurodegeneration in AD, PD, and other neurodegenerative diseases, thereby aiming to restore brain function
and improve the quality of life for patients.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #222222"><FONT STYLE="font-size: 10pt; background-color: white"><B>References</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><I>1.</I></FONT></TD><TD><FONT STYLE="font-size: 10pt"><I>Holden,
                                            SK, Finseth, T, Sillau, SH and Berman, BD. Progression of MDS-UPDRS Scores Over Five Years
                                            in De Novo Parkinson Disease from the Parkinson's Progression Markers Initiative Cohort.
                                            Mov Disord Clin Pract 2018, 5: 47-53. [<U>PubMed</U>]</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><I>2.</I></FONT></TD><TD><FONT STYLE="font-size: 10pt"><I>Jankovic
                                            J, McDermott M, Carter J, et al.&nbsp;Variable expression of Parkinson's disease: a base-line
                                            analysis of the DATATOP cohort. The Parkinson Study Group.&nbsp;Neurology&nbsp;1990; 40:1529&ndash;1534.
                                            [<U>PubMed</U>]&nbsp;[<U>Google Scholar</U>]</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><I>3.</I></FONT></TD><TD><FONT STYLE="font-size: 10pt"><I>Stebbins
                                            GT, Goetz CG, Burn DJ, et al.&nbsp;How to identify tremor dominant and postural instability/gait
                                            difficulty groups with the movement disorder society unified Parkinson's disease rating scale:
                                            comparison with the unified Parkinson's disease rating scale.&nbsp;Mov Disord&nbsp;2013;
                                            28:668&ndash;670. [<U>PubMed</U>]&nbsp;[<U>Google Scholar</U>]</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt"><I>4.</I></FONT></TD><TD><FONT STYLE="font-size: 10pt"><I>Goetz,
                                            CG, Choi, D., Guo, Y., Stebbins, GT, Mestre, TA.,&nbsp;&amp; Luo, S. It Is as It Was: MDSUPDRS
                                            Part&nbsp;III Scores Cannot Be Combined with Other Parts to Give a Valid Sum. Movement Disorders
                                            2023, 38(2), 342-347. [<U>PubMed</U>]</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #222222"><FONT STYLE="font-size: 10pt; background-color: white"><B>About
Annovis Bio,&nbsp;Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt; background-color: white">Headquartered
in Malvern, Pennsylvania, Annovis Bio Inc. is dedicated to addressing neurodegeneration in diseases such as AD and PD. The company&rsquo;s
innovative approach targets multiple neurotoxic proteins, aiming to restore brain function and improve the quality of life for patients.
For more information, </FONT><FONT STYLE="font-size: 10pt">visit <U>www.annovisbio.com</U> and follow us on <U>LinkedIn</U>, <U>YouTube</U>,
and <U>X</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">Interested investors and
shareholders are encouraged to sign up for press releases and industry updates by registering for Email Alerts at <U>https://www.Annovisbio.com/email-alerts</U>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #222222"><FONT STYLE="font-size: 10pt; background-color: white"><B>Forward-Looking
Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #222222"><FONT STYLE="font-size: 10pt; background-color: white">This
press release contains &quot;forward-looking&quot; statements within the meaning of Section&nbsp;27A of the Securities Act of 1933, as
amended, and Section&nbsp;21E of the Securities Exchange Act of 1934, as amended. These statements include, but are not limited to, the
Company's plans related to clinical trials. Forward-looking statements are based on current expectations and assumptions and are subject
to risks and uncertainties that could cause actual results to differ materially from those projected. Such risks and uncertainties include,
but are not limited to, those related to patient enrollment, the effectiveness of buntanetap, and the timing, effectiveness, and anticipated
results of the Company's clinical trials evaluating the efficacy, safety, and tolerability of buntanetap. Additional risk factors are
detailed in the Company's periodic filings with the SEC, including those listed in the &quot;Risk Factors&quot; section of the Company's
Annual Report on Form&nbsp;10-K and Quarterly Reports on Form&nbsp;10-Q. All forward-looking statements in this press release are based
on information available to the Company as of the date of this release. The Company expressly disclaims any obligation to update or revise
its forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>Contacts</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">Annovis Bio,&nbsp;Inc.<BR>
101 Lindenwood Drive<BR>
Suite&nbsp;225<BR>
Malvern, PA 19355<BR>
<U>www.annovisbio.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>Investor Contact</B><BR>
Scott McGowan<BR>
InvestorBrandNetwork (IBN)<BR>
Phone: 310.299.1717<BR>
 &zwj;IR@annovisbio.com<BR>
<U>Investor Website</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 6; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>anvs-20240702.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.22c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWa+EabOdzZR+WYkxtmB2bUk6ryku6EoXDiEN8aFmYUcJ -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:ANVS="http://annovisbio.com/20240702" elementFormDefault="qualified" targetNamespace="http://annovisbio.com/20240702">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://annovisbio.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="anvs-20240702_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="anvs-20240702_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>anvs-20240702_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.22c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>anvs-20240702_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.22c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://annovisbio.com/role/Cover" xlink:href="anvs-20240702.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://annovisbio.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>tm2418712d1_ex99-1img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2418712d1_ex99-1img001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #X DX# 2(  A$! Q$!_\0
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M)PN/4^U>BZ3<VDWB#4%2&_CO/LMK)-]I;Y"K!]NU<D*PPP;@<XZXH W:***
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M)UEC:-XW4X965@"""*TJQ_#NA#0+>^B%P9_M=_<7N=FW;YKEMO4YQG&>];%
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MGM6AXD\5'P_+'##H^H:E*T,EQ(+55"Q1)C<S,Y SSPHY-<'X+\#ZCX=N=/\
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M"W R=N<5LVM_9WN_[)=P7&S&[RI ^W/3..G0T 6**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#@_AC_S
M.7_8T7O_ +)7>5P?PQ_YG+_L:+W_ -DKO*Z,3_%?R_)"6P4445SC.;\?65]J
M/@J_M=,5FO',7E!1D@B5#G'? !/X54TFQ\8#4XVO/%FF7EK#)BX@ATX(Q_V=
MV\[3^%7/'L.HW'@C5(M*6=[ID7Y+<XE>/>OF*G^T4W@>Y%<%I<?A.?Q/H!\!
M:7=6UY#<_P"GRQVDT");;&WI*7 #$G;CJ<C.?4 ]@HHHH ;)&DL;1R(KQN"K
M*PR&!Z@BLJ+PMH$%E'90Z-8Q6L<IF2&.!557*E2P '7:2,^AK7HH RM'\-:'
MX?:9M(TJTL6F $AMX@F_&<9Q]363)_R5NV_[ 4O_ */CKJZY23_DK=M_V I?
M_1\= '5T444 %%%% !1110 4444 %%%% !1110 4444 17,K0VSR* 2HR,UD
M_P!L7']R+\C_ (UMT4 9MCJ$MS<>6ZH!@G@'_&HO$UU<V>A2S6AE$_FPHOD[
M=YW2JI"[_ER02!GCFM>FNBR+M=0PR#@C/(.10!P5UKNNZ'=QSW\LD5E)Y[Q0
MW_EF3"Q+@.80PQOSC;D\\]@)+7QQ>W2RQ[=-MY;9I_.DNY&B1EB$3$ <E3^^
M&2<[=O0YP.WEMX;@8FACD&"N'4'@C!'/J*@72]/5$1;"U"(XD11"N%8  ,..
M#@#GVH X6?QSJMS#)Y-O;V>ZXA\F665?E47D4+*XR2<JYR0!MP1UP:NKXVO=
M[AH;$BU=$G"2DM<;KAX,PC_MGG!SDG;VR>O.G63&8FSMR9R#-F)?WA'3=QS^
M-*+"S!@(M( ;<8A/EC]V/]GCC\* +%%%% !1110 5QFN>/8?#WC0Z1?6\[VC
M:<ETCVMK)-)O,CJ0=N<+A1VZ]Z[.N'UR[U#_ (3T6?AK3[ ZT=,5[F^U"63R
MH[?S6"($0_,Q;><\8'?I0!N^'_%-AXE^T?88KV/[/MW_ &JTD@SNSC&\#/W3
MTZ<>M;=<QX7\0:GJ&HZIHVN6EM!JFF^4SO:2%H9HY 2K+NY'W6!!].O-=/0
M4444 <SH/@NPT[P?:>'M4AM=6AMY))/](ME9"S2.X.UL@$;R,UF^%-,L-)^(
MOBVUTVRMK.W%KI[>5;1+&F3Y^3A0!FNXKD=$_P"2G^+?^O/3OY3T ==1110
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MC-!<AW"[0#T-:=%%:TZ:IJR-Z5*-*/+$****T-0HHHH **** "BBB@ HHHH
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MG\^'>FFL$G>/S%WA&)^4[<\U3\!1O&M^'MO%$!S&<:_=><3][_5_,V/?IVH
MZN\N[?3[&XO;J416UO&TLLAZ*BC)/X &LS1/%.FZ]9W5Q;&>+[*1Y\=S"T3Q
M@H'4E3V*D$&HO$_AN3Q%875L-5O+5)[.:V,,97RG+HR[G!7<<9SPPZ5E>']
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MT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '
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M35R.B?\ )3_%O_7GIW\IZK>'M9UK3_"DE]J-EJ^L*]ZZV*I!&+MK4CY'E4E
M#PWH<%<C.:@\&:F^K?$#Q9=2:;?:>QMM/7R+U%63CS^<*S#'XT =Q<VL=T@6
M0M@'/!K$UNW33K"*>')=KRU@.XY&V2>.-OQPQQ[UT-8GBO\ Y \'_82L/_2N
M&@"Y_9%MZR?F/\*O* JA1T Q2T4 %%%% !1110 4444 %%%% !1110 4444
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M!8&NCK'\3?\ (*@_["%C_P"E45  -'D!!\U./8UL444 %%%% !1110 4444
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M]&>SNX+A5.&,,@< ^^*L4BJJ_=4#Z"EH **** "BBB@ HHHH **** "BBB@
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M\KHQ/\5_+\D);!1117.,**** "BBB@ HHHH **** "FO&DBXD17'7##-.HH
MA^R6W_/O%_WP*XVRG\2/\0+FTN-,MAH>"D<XMF"_+EN#UW$21C<?E)B<  UW
M%% $/V2V_P"?>+_O@5(B+&NU%"KZ 8%.HH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *YS7(=>@EN;ZU,&J62QKL
MT<P+&[L",L)F)&1R0"O) &1UKHZ* . \*^&M2F\+7MI=76K:+YVJ37=NZ31_
M;#$W/[YL.I8L6/<X"\\5O>'?"4/AZ_U"^_M74]1NKY8DEEOY$<@1[MH&U%_O
MGU[5T-% !1110 4444 %<-!:>,Q\19)Y;IO^$?8F-?D3.U?G'R[\!27*;PN_
MY!D8YKN:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH X/X8_\ ,Y?]C1>_^R5WE5+#2['3/M/V*V2#[5</<S[/XY6QN8^Y
MP*MUK5FIS<E_6B_R$M HHHK(84444 %%%% !1110 4444 %9FJ6^IO<6D^FR
MP@Q%_,BG=E20$8'W>X-:=% &+N\3?\\=(_[^R?\ Q-&[Q-_SQTC_ +^R?_$U
MM44 8N[Q-_SQTC_O[)_\31N\3?\ /'2/^_LG_P 35_4Y;J#2[F:R5&N(XRZ*
MZ,X)'.,+R?H*P? M_P"([_296\2V8M;J-]H1E.\Y^;)( 4C#*!MZ$$'D4 7]
MWB;_ )XZ1_W]D_\ B:-WB;_GCI'_ ']D_P#B:VJ* ,"XA\2W4:PLVG0(9$+2
M0RR;PH8$@<#J 1^-;]%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 445QDOB34-.\>7<%ZZ-H),%LK;0#:
MSNN5)(ZJY^7GHVSL30!V=%<OX:UR]N?AUIVLWC)<WDEJLDA=TA#L3W. JU?T
M+6Y=7,XDMH(?*VX\J\2?.<]=O3IWH V:*\[T?Q9=WFK1:A>:C=VVF37MS;HD
MMG&+3;&7"J).)!)\FXL24SN4#/-;'AKQ!>ZSXFU5)BB:?]CM;BQAV@.$=YU+
MMWRWEJV.P*C .: .LHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BN>\<O-'X,U(
MV]Q-;2E%59H'*.F7495AT/-9&CZQ?R>-['0]1G;[=9:==_:54D)<CS+813[>
MGS O_NMO ]P#N**Y.\UK7XO$GV2&TW6/G(N_^SI6^4XR?,$@7N><<5#XSAOK
MF_MC;74(@M;.>XGM?[7FL9),&/#YBYV@!QDG +@]J .RHK@A*VK:GIL^D7VJ
MM>2?9+IX6N'$-E:D(725<[6=U#XW;GRV> ,U+I<TEIXSL_+U2XO;'48;G$K7
M9E6:574\1_=B" ,HV<'//(&0#N**** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K+G\/V%T=4%S&TT>IQK
M'<1N?E*JI48[C@UJ44 9FDZ%9:1X?M=$C5I[.VB$2BXPY91_>XP?RJW:V%G9
M%OLEI!;[\;O*C"9QTS@58HH YP>#-.^VF26>ZFLO/DN5TV5D:V663=O;;MW'
M)=SM+%<L2!FK.F^$M#TC69]4T[3;6UN)H$@(@@1%559VR, 8)W\\\[5]*VJ*
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH CGMX;J%H;B&.:)OO)(H93WY!IIM;
M<WBWAMXC=+&8EF*#>$)!*ANN"0#CV%%% $U4M1T;2]7$0U/3;.]$+;H_M,"R
M;#ZC<#@_2BB@"O-X8T"XU,:E/H>F2WX=7%T]I&TNY<;3O(SD8&#GC J>VT;2
M[*^GOK33;."\N/\ 77$4"K))SGYF R>?6BB@"]1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
I10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>tm2418712d1_ex99-1img002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2418712d1_ex99-1img002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &> =$# 2(  A$! Q$!_\0
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M<_:)&D 6+ W'<?X< @\]C4<.JZ=<7(MH+ZVDG)<"-)5+97;NXSVWIGTW#UH
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MBF.*.10BE4P #(>Q)]:W-1L-6LOAY=PQ:Q<G4TM9)I+P#<[/@LP0'[HSPO\
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M+K6X]*ET;5K.27S/+FNH46-]G7!#$_I0!T%%%% !1110 4444 1SPI<0202
MF.12C ,5.",'D<C\*99V=MI]E#9VD*0V\*!(XT& H':IZ* "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHI&940LS!549))P * %HI 0P!!!!Y!%+0
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MA5&UAA< ^60,XJ?XA%/^$MTT&QOIP$B:80S%(I8_,==K81LMN<  %<^9SP*
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MUMIQ6">W?[1;^;N679G'SK@C9UYZUK>&-,GTRRNOM.H07T]U=/<22P1>6F6
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M'@9/7GISTKBE\$:W//9+=30-;A6:5&FG(5I#([KQ+SAO*Z=<9['/<?V=>?\
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M;0258 $]OI575?\ D;O#_P!+G_T 54/A"9==TZ]75I9K*QRZ6EZ)+@^8Q.9
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MN=P/JM>U>&K+5-.\.V5IK6H#4-1B0B:Y"XWG)(_(8&>^,T >??!#_CW\4_\
M86?^5>K5Y3\$/^/?Q3_V%G_E7JU=>-_CR^7Y(F.P4445R%!1110 4444 %%%
M% !16%XCU.^TO[)-:1F6(,[7,:IN8QA#RON#\V.^".]']I:J+32WALC<&>%&
MG? &TD#/<>IH W:*P-<O-2MKJ5+:YBBB;3KB1"T1/ERJ8P'9L-D .>-O8YSV
MQ+'Q!JLVN:9 9RUL_P L@)1C/\TRET(C7>HV1G(VX4@D-NH [JBBB@ HHHH
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M_P#"UC>6UX]MY4DJM#'"P<KA0"681QY)(SRI/JS&NOH **** "BBB@ HHHH
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MG-<=9>'==T_QU;W4$US)HXC"R"YOI) H\HCY5W==^"0P8<DA@<"NZH ****
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M6X+6R2Z?;PO--%'A[H_,)/)(V?)\S 3<CC[O7GBS0L6O@N&V,!-]([1[%?\
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M6F]7VL[91-BC<Q;"KDX49P!GH!2:1J(U73ENQ%Y>9)(RNX-@H[(<$=1E:O4
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M08K+&G6.G_$K3!96=O;!]'O-WDQ*F[$UKC.!SUKK:YNZ_P"2EZ3_ -@>]_\
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MJSZHDK3Z-J&FF,@ 7GE9?/IY;MT]\=:TJ**YCSPHHHH **** "BBB@ HHHH
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M(N_ !YX+1_\ ?7MST7AR]M[[1DEM+06D*RR1K$""!M=@2,<<D9_&@#5HHHH
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M11*$0,Q8@#IR>:KIHNE12+)'IEFCH0RLL"@J1T(.*O4 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% &/%J6IOXJGTY]+9=-2!7CO2QPS_Q
M+T_VEQ]&Y."!-<:]I5M+=6[:A:-=VL+32VPN(Q(J 9R0S#:,=S@<]:TJXN?P
M=J-SJU]</?6RVUU("\21O^\'FH22"Q57\I6CRH&[()Z8H Z,Z_HZS3POJMBD
M]NI:>)KE-T( +'>,\8 )Y[ U6N_%FB6NFG4?[2M)K)6=7GAN8V5"BEF_BY/
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MEO<3QHOE^;YS)(XF24LR%RJ!C&O"  $9YJQ>> KC4-7CO;J\B82QQK>+"T\
M;;(\A"I'(JL#OQ\X8C&><T =):>)-)N[F^MUOH$FL6<3QR2H&55X9R,Y"YXR
M<=*O6.H66IVJW5A=P7=NQ(66"02(2.N"#BN,?P-J%Q $N+VQW02O<0!+=L22
M/.D[^;\W*G9LP.H8D]@.GT33)].CO);N6*6[O;@W,YA0J@;8J *"2<!47GN<
MGC.* -2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MC*9OM*W/WAC<L1B Z?= 8G']XYK/7P7IV\&2>\E2-@8(I) 5@'FK(548Z$H
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944 %%%% !1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>tm2418712d1_ex99-1img003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2418712d1_ex99-1img003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &[ B8# 2(  A$! Q$!_\0
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M5C>"YLF;RM16R0VL9(13 DN^3)X&6(S_ +M=;0 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !17E^N_%&^T;5O%%@;"W9K
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MXV#9*,"?E(SQ@%A_%Q@,J?"M;&/1+R'3YM'EB289.FPSH,[0/G,S,S' &.>
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M)'B&_8ZI9;3;P '[0F#\TOO6C_;VC_\ 06L?_ A/\:SO^$"\'?\ 0JZ)_P"
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >4:VOB+PM\3-6
MU_PYI5OK\.I00I>V27"I/;NB[5/<A2,'H<Y[<5L?#O1=>75_$'BGQ':16%]K
M+PA;*)]WE1Q*5!8@D9((]^.V<#"\7:=KOAWX@7GB?2]?\+:1%J$$<+KJL[(T
MY0 9((ZC 'RD<8S78^"+SQ'J%K<W6N:EX?O[=]OV271G9TXW;]Q/!_AQCWH
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MY9W@E^>X1) KHZM@(2Q _NY/%>G5B^)=:70K*"X-E]K>:=8$4R)&JD@G+.Y
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M_P#;3_T8U &&VJW)<D>']:Y/_/K_ /7IT&KW$=Q&[:!K6%8$_P"B^_UKNJ*
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MNM_\>EM_U^6__HU:QJ485'>1SU</"J[R$MM.FAN$D9D(7K@G_"IM7_Y!<W_
M?_0A5VJ6K_\ (+F_X#_Z$*THTXTVE'N;X6E&E)*/<Y:K^C_\A.+Z-_(U0J_H
M_P#R$XOHW\C7I3^%GO5?X<O0Z>BBBO//""BBB@ HHHH **** "BBB@ HHHH
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M(VH?Q(G-UL:!_KYO]T?SK'K8T#_7S?[H_G775^!GJ8C^$S>HHHKA/%"BBB@
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MD_G2T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!7&>*=#N=0\26EZ_AVTUVSAM&B6"[F54BD9P2P5P020 ,XS79T4 <WX(TN]T
M?09+2\MH[0?:YY(+6.0.L$3N65 0 ,#.,=JZ2BB@ KD)OB3H26MS<PI>7,=O
M=2V[>1#NR(HUDDD'/,85@<]^P/%;VL:+:ZW:_9[J6\C49P;6[E@/(QSL8;OH
MV1[5Q_\ PJJW@MKF&SUN^A$SN 7 DV1/ L+(,]]J##=L 8(% &[XUE2?P+J$
ML3!HWB1E8=""RD&NDK!D\%>&)KA+B?0=.GN45%$\UNKR?(H5<L1G@*!^%;U
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M<57 )[X&3C\S3J ,FXUJ("+R+*]GD::.,!K.5 H9U!8L4P H.[_@/:M:BB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
..**** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139707816767472">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jul. 02, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul.  02,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39202<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ANNOVIS BIO, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001477845<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">26-2540421<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">101
Lindenwood Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 225<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Malvern<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">PA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">19355<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">484<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">875-3192<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ANVS<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$
MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7<K_WUE[O)I#-ZG7TZSFN4
M?VFK :?MNYO/D_QSZ.2?IY/734+.<+PL"?'[(UMAAR=N.Q-R.AQG0GS/]O:1
MI24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG LR+7E$8D19_(
M+;KD$3BU20TR$S\(G8:8:E < J0),9:AAOBTQJP1X!-]M[X(R-^-B/>K;YH]
M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M
MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZ<TT#PE"\D^DJ1CVFS(Z=T)LWH
M,QK!1J\;=8=HTCQZ_@7YG#4*')$;'0)G&[-&(81IN_ >KR2.FJW"$2M"/F(9
M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+
MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T
M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
M" # 0>)8M]?5)8X$  #'$0  &    'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;(V8;W/B-A#&W_=3:'R=3CN3!$O\30K,$)*T]"Z$"5QNVDY?"%N )K;E2G)(
MOGU7AMA<:M:\ =MX'W[>73V2W-\J_6PV0ECR&D>)&7@;:].K1L,$&Q%S<Z%2
MD< O*Z5C;N%4KQLFU8*'>5 <-9CO=QHQEXDW[.?79GK85YF-9")FFI@LCKE^
MNQ:1V@X\ZKU?>)3KC747&L-^RM=B+NS7=*;AK%&HA#(6B9$J(5JL!MZ(7EVS
MC@O([WB28FL.CHE[E*52S^YD$@X\WQ&)2 3627#X>A%C$45."3C^W8MZQ7^Z
MP,/C=_6[_.'A89;<B+&*OLG0;@9>SR.A6/$LLH]J^[O8/U#;Z04J,ODGV>[N
M;?L>"3)C5;P/!H)8)KMO_KI/Q$% BQT)8/L EG/O_BBGO.&6#_M:;8EV=X.:
M.\@?-8\&.)FXJLRMAE\EQ-GA6+T(W6]8D'(7&L$^['H7QHZ$_9%%%\1G9X3Y
MK/5]> ,("@Q68+!<KXEAD+]'2V,U%.J?*J*=0JM:P77OE4EY( 8>M*<1^D5X
MPY\^T8[_*\+7+/B:F/KP1@49]*(EB[=45,'AX;WSSPA$JX!HH2HC( ASBKN(
MKZLH\/@5CXQ .-H%1_NT9,R$EBHDMTE(H/DJ\X(KY6V4]U%=(W4*M@ZJ>)M8
M:=_(G8P$F6;QLKJY<0W?I^?-2P!">+H%3_<4GD>QEJZU(6E3'E=F"M<93:</
M3Y,YN9X\G)')='R!L/4*MMXI;&,HI>81F22A>"6?Q5L5':[D0\I:W6ZOU4:P
M+@NLRU.P%OR53$)@DRL9\-S"CQ<45V2=<]9N^2U&$3SJEY;IGP(X20*E4Z5S
MMC,RMS $B-)DK#)(*.15A96%KE&_N<4@#WR=G@(Y"D-P0W/V?D"^P'WD(:DF
MPR6I3W^ <*C)5L&PO]$PGV*LI?E3U+MQUL565;+BDO-,0C48PQJ2ENY/<?_^
M"#AV9U#JA=HFE7"XW#V/8+I+,+1R3J"XJ7]$*]IPIM6+3(+J0N.:LQ&&5DX3
M%'?WCV@S92SXS%\R/3XV<$5ZV6RC%2VG"8I[?%[!$:QCCZ/@ JT>-EW1<GZ@
MN+%_40'D9+91"39AU8CTNNWS)KW$)BQ:S@H4-_-O6EHK$DA,'&?)WGM-)14N
M5+?>H.6,0'$#GZM(!M+*9$WNH;VUY%$E#ZY2Q\/*&8#A'CW3XCR ] @87[ME
M(:S,8 '[L%I5UZ]&KY:LM'V&>_3_R";&9$!6"XC+U@(>+/1Q8UY("TLSM2*4
M_;S\A<Q%D$&_5:XY:I1<?\*B8&Y5\'Q&4J[)"X\R07[T+]QZA*3PO&;#-<I=
M3@$,]^R%YJ'KO_E;O%25W5<C,)H^S3&2TO$9[L[O*2.WK\&&)VMQ=$E9(S3]
M<XZM-5AI].PDH[^-A5Z['/T&"G;C#"3E275I<4&K,[1JI<VSFNV V_V+D$P5
MC%%%OAI![$9 YJP;#R&!JB9&YHO+W6:F$A;_CZ-CHW&P+7>O..ZY2X\AD5B!
MD'_1A23HW5N#W8E5:;Y37RH+^_[\<",XC%MW _R^4LJ^G[C-?_'N9O@?4$L#
M!!0    ( ,!!XEB?H!OPL0(  .(,   -    >&PO<W1Y;&5S+GAM;-U7;6O;
M,!#^*T(_8&YB:N*1&+9 8;"-0O-A7Y58=@1Z\62Y<_KKI[-L)VEU9=V'L<VA
MR=T]NKM'=R>9KEMWDOSAR+DCO9*ZW="C<\W[)&D/1ZY8^\XT7'ND,E8QYU5;
M)VUC.2M;<%(R6=[<9(EB0M-BK3MUIUQ+#J;3;D-O:%*L*Z//EI0&@U_*%">/
M3&[HEDFQMV)8RY20IV!>@N%@I+'$>2I\0Q=@:9\"O @:L!SC**&-!6,2,H3O
M_;C\&3!IK5>%E#/!)0V&8MTPY[C5=UX9%@_&%Q 9Y=VI\0QKRTZ+Y2T].PP_
M/LG>V)+;.<V"3J9B+7D%=*RHC_#K3), Z)Q17B@%JXUF X?)8Q1\V .7\@%:
M^*VZBMU7)/3B4PEM(+#52?2$1C&$"0K$OXP68E^$O?VML*01C\9][/QN]*!_
M[XSC]Y97HA_TOIKS8]$7>'36-/+T08I:*Q[V_LL)BS6;_,C16/'DL\&D'+R!
M6TH>N77B<&GY85FSX[V;IJFO<,[+?Y#SGZUSS36W3%Z2]J/_-U?Y+8R3\?1<
M'-&K SI;"5R$&_H5[E=YYD#VG9!.Z%$[BK+D^L4Y]>$=V_L+_"J^7U_RBG72
M[69P0\_R%UZ*3N7SJGNHR[CJ+'^&^VB1S;>PSR5TR7M>;D?5UOM!)%[P6<<'
M')XC=\,31S"?@,41P+ \& /,)WAA>?ZG_:S0_00,X[:*(BO49X7Z!*\8LAT^
M6)ZX3^Z?^$[S/$VS#*OH=AMEL,7JEF7P%X^&<0,/+ ]D>ENM\6[C$_+Z'& ]
M?6U"L)WBDXCM%*\U(/&Z@4>>Q[N-Y0$/K O8[$#^>!Z8J;A/FD)7,6[8"<:1
M/,<0F,7XC&894IT,/O'^8*<D3?,\C@ 69Y"F& *G$4<P!L !0])T> \^>Q\E
MTWLJ.?]74_P$4$L#!!0    ( ,!!XEB7BKL<P    !,"   +    7W)E;',O
M+G)E;'.=DKENPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_K]JE<9 +
M&7D]/!+<'FE [3BDMHNI&/T04FE:U;@!2+8ECVG.D4*NU"P>-8?20$3;8T.P
M6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^ KSI,<4)I2$LS#O#-TG\R]_,,
M-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE?QW']I#3Z:]C(K1Z6^CY<6A4
M"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ P$'B6*K$(A8S 0  (@(   \
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M4$L! A0#%     @ P$'B6(:UA;+O    *P(  !$              ( !KP
M &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ P$'B6)E<G",0!@  G"<
M !,              ( !S0$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M    " # 0>)8M]?5)8X$  #'$0  &               @($."   >&PO=V]R
M:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ P$'B6)^@&_"Q @  X@P
M  T              ( !T@P  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " #
M0>)8EXJ[',     3 @  "P              @ &N#P  7W)E;',O+G)E;'-0
M2P$"% ,4    " # 0>)8JL0B%C,!   B @  #P              @ &7$
M>&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ P$'B6"0>FZ*M    ^ $  !H
M             ( !]Q$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L!
M A0#%     @ P$'B6&60>9(9 0  SP,  !,              ( !W!(  %M#
G;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  )A0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2418712d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://annovisbio.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>anvs-20240702.xsd</File>
    <File>anvs-20240702_lab.xml</File>
    <File>anvs-20240702_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="tm2418712d1_8k.htm">tm2418712d1_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tm2418712d1_8k.htm": {
   "nsprefix": "ANVS",
   "nsuri": "http://annovisbio.com/20240702",
   "dts": {
    "schema": {
     "local": [
      "anvs-20240702.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "anvs-20240702_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "anvs-20240702_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "tm2418712d1_8k.htm"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 24
   },
   "report": {
    "R1": {
     "role": "http://annovisbio.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2024-07-02",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2418712d1_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-07-02",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2418712d1_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://annovisbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001104659-24-077093-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-24-077093-xbrl.zip
M4$L#!!0    ( ,!!XEAZFX,R+ ,  .D+   1    86YV<RTR,#(T,#<P,BYX
M<V2U5MMRVC 0?>],_T'U:\8VF.9&3#)I$CIT2-*!DMM+1\B":) E5Y*!].LK
M^<;%0("V/,F[YYS=]>[*^!?3D((Q%I)PUK"J3L4"F"$>$#9L6+VN?=F]:K4L
M<''^\0/0/_^3;8,FP32H@VN.[!8;\#-P!T-<!U\QPP(J+L[  Z2QL? FH5B
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M\3Z$GI!&:(3"@H&G/6U8KB@L4?C.LI&!B:.[[FC4H:1OFT/"'4%N!@C2:#3
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MTH>SL_,K7CD]]222P3]2XO[Y&V>HE_\/4$L#!!0    ( ,!!XEC[L8=)1Q4
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MD0JFP#AZBOG .P%$ )@4!=P+\2(GXPE3!-Q'>83OF"?B0#EB+#SX5AM7&:K
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MN;F^45*R%F1&CXU?GB@U!HKT[8ER>? J4/<)U'WV_"^4M/6G25J2J"RWD4[
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M??]NEWW0X':'G6%)YD^C_G\R7;R&O[1SGWZ+)_ZRS_\'4$L! A0#%     @
MP$'B6'J;@S(L P  Z0L  !$              ( !     &%N=G,M,C R-# W
M,#(N>'-D4$L! A0#%     @ P$'B6)8CKTW]"@  @(8  !4
M ( !6P,  &%N=G,M,C R-# W,#)?;&%B+GAM;%!+ 0(4 Q0    ( ,!!XEA$
M 3JJ60<  -E7   5              "  8L.  !A;G9S+3(P,C0P-S R7W!R
M92YX;6Q02P$"% ,4    " # 0>)8/FV'NTT3  #=:@  $@
M@ $7%@  =&TR-#$X-S$R9#%?.&LN:'1M4$L! A0#%     @ P$'B6/NQATE'
M%0  \W,  !8              ( !E"D  '1M,C0Q.#<Q,F0Q7V5X.3DM,2YH
8=&U02P4&      4 !0!) 0  #S\

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>tm2418712d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="anvs-20240702.xsd" xlink:type="simple"/>
    <context id="AsOf2024-07-02">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001477845</identifier>
        </entity>
        <period>
            <startDate>2024-07-02</startDate>
            <endDate>2024-07-02</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2024-07-02" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2024-07-02" id="Fact000004">0001477845</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2024-07-02" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2024-07-02" id="Fact000010">2024-07-02</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2024-07-02" id="Fact000011">ANNOVIS BIO, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2024-07-02" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2024-07-02" id="Fact000013">001-39202</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2024-07-02" id="Fact000014">26-2540421</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2024-07-02" id="Fact000015">101 Lindenwood Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2024-07-02" id="Fact000016">Suite 225</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2024-07-02" id="Fact000017">Malvern</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2024-07-02" id="Fact000018">PA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2024-07-02" id="Fact000019">19355</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2024-07-02" id="Fact000020">484</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2024-07-02" id="Fact000021">875-3192</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="AsOf2024-07-02" id="Fact000022">Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2024-07-02" id="Fact000023">ANVS</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2024-07-02" id="Fact000024">NYSE</dei:SecurityExchangeName>
    <dei:WrittenCommunications contextRef="AsOf2024-07-02" id="Fact000025">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2024-07-02" id="Fact000026">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2024-07-02" id="Fact000027">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2024-07-02" id="Fact000028">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2024-07-02" id="Fact000029">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="AsOf2024-07-02" id="Fact000030">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
